Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Alpha-tocotrienolquinone----1件: 18 💬
2Artesunate1件: Artesunate1件: Artesunate 💬--3件: 18, 66, 96 💬
3Artesunate Oral Product1件: Artesunate1件: Artesunate 💬--1件: 18 💬
4Baclofen1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206 💬
5BINOCRIT*1SIR 40000UI/1ML1件: Erythropoietin---1件: 18 💬
6Bupropion1件: Bupropion1件: Bupropion 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬5件: 8, 18, 21, 96, 171 💬
7Bupropion & Citalopram2件: Bupropion,
Citalopram		2件: Bupropion ,
Citalopram 💬		3件: SLC6A2,
SLC6A3,
SLC6A4 💬		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 18 💬
8Butylphthalide1件: Butylphthalide---4件: 2, 6, 18, 22 💬
9C-Trelin OD Tab(5mg Taltirelin Hydrate)----1件: 18 💬
10Cabaletta1件: Trehalose---2件: 18, 113 💬
11Cabaletta for IV infusion once weekly during 24 weeks1件: Trehalose---1件: 18 💬
12Calcitriol1件: Calcitriol1件: Calcitriol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬9件: 18, 37, 46, 49, 66, 96, 158, 235, 326 💬
13Carbonate1件: Carbonate ion---12件: 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬
14Citalopram1件: Citalopram1件: Citalopram 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬7件: 6, 8, 13, 18, 46, 98, 127 💬
15Coenzyme Q101件: Ubidecarenone1件: Ubidecarenone 💬--11件: 2, 5, 6, 8, 10, 18, 46, 57, 113, 214, 215 💬
16CTI-16011件: CTI-1601---1件: 18 💬
17DEFERIPRONE1件: Deferiprone1件: Deferiprone 💬--6件: 2, 6, 18, 120, 122, 233 💬
18DT-216----1件: 18 💬
19EGB 761 (r) 120 mg----1件: 18 💬
20EGb 761 120 mg----1件: 18 💬
21Epoeitin beta----1件: 18 💬
22Epoetin alfa1件: Erythropoietin---3件: 13, 18, 46 💬
23EPREX*1FL 40000UI/ML 1ML----1件: 18 💬
24EPREX*1SIR 10000UI 1ML----1件: 18 💬
25EPREX*1SIR 40000UI/ML 1ML----2件: 2, 18 💬
26ERYTHROPOIETIN1件: Erythropoietin---9件: 2, 6, 13, 18, 22, 47, 70, 95, 96 💬
27ETRAVIRINA1件: Etravirine1件: Etravirine 💬--1件: 18 💬
28Etravirine1件: Etravirine1件: Etravirine 💬--1件: 18 💬
29Etravirine Tablets1件: Etravirine1件: Etravirine 💬--1件: 18 💬
30EU1/97/031-032----1件: 18 💬
31EU1/97/031/031-032----1件: 18 💬
32Flumazenil1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206 💬
33Gamma interferon----1件: 18 💬
34Ginkgo1件: Ginkgo biloba---5件: 6, 13, 18, 47, 90 💬
35Ginkgo biloba1件: Ginkgo biloba---4件: 13, 18, 47, 90 💬
36Glentek 50 mg compresse rivestite con film----1件: 18 💬
37Glentek 50 mg film-coated tablets----1件: 18 💬
38Granocyte----2件: 18, 57 💬
39H-116PI-DE.pdf----1件: 18 💬
40High Dose LX2006----1件: 18 💬
41High-dose intravenous immunoglobulin (IVIG)----1件: 18 💬
42Idebenone1件: Idebenone1件: Idebenone 💬--6件: 6, 8, 13, 18, 113, 302 💬
43Imukin----3件: 18, 58, 228 💬
44IMUKIN - 6 FLACONI 0.5 ML 100 MCG----2件: 18, 58 💬
45IMUKIN*SC 6F 0,5ML 100MCG----1件: 18 💬
46INTELENCE1件: Etravirine1件: Etravirine 💬--1件: 18 💬
47INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE1件: Etravirine1件: Etravirine 💬--1件: 18 💬
48Interferon Gamma1件: Interferon Gamma---8件: 18, 65, 85, 107, 228, 299, 301, 326 💬
49INTERFERON GAMMA-1B2件: Interferon Gamma,
Interferon gamma-1b		1件: Interferon gamma-1b 💬2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬7件: 18, 65, 85, 228, 299, 301, 326 💬
50Iron1件: Iron---6件: 18, 96, 97, 238, 254, 284 💬
51Iron chelating intervention1件: Iron---1件: 18 💬
52J05AG04----1件: 18 💬
53KPS-0373----1件: 18 💬
54KPS-0373, High dose----1件: 18 💬
55KPS-0373, Low dose----1件: 18 💬
56Lenograstim1件: Lenograstim1件: Lenograstim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬7件: 2, 13, 16, 18, 19, 57, 65 💬
57LITHIUM CARBONATE3件: Carbonate ion,
Lithium carbonate,
Lithium citrate		2件: Lithium carbonate ,
Lithium citrate 💬		--5件: 2, 13, 17, 18, 127 💬
58Low dose LX2006----1件: 18 💬
59Lu AA24493----1件: 18 💬
60Methylprednisolone1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
61MIB-626----1件: 18 💬
62MIN-102----2件: 18, 20 💬
63Neo-Recormon----1件: 18 💬
64NeoRecormon1件: Erythropoietin---2件: 13, 18 💬
65Nicotinamide1件: Nicotinamide1件: Niacinamide 💬--8件: 2, 6, 18, 49, 97, 107, 162, 191 💬
66Nicotinamide riboside2件: Nicotinamide,
Nicotinamide riboside		1件: Niacinamide 💬--5件: 2, 6, 18, 97, 191 💬
67Omaveloxolone1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
68Omaveloxolone Capsules, 10 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
69Omaveloxolone Capsules, 150 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
70Omaveloxolone Capsules, 160 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
71Omaveloxolone Capsules, 2.5 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
72Omaveloxolone Capsules, 20 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
73Omaveloxolone Capsules, 300 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
74Omaveloxolone Capsules, 40 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
75Omaveloxolone Capsules, 5 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
76Omaveloxolone Capsules, 80 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
77PTC743----2件: 18, 21 💬
78Resveratrol1件: Resveratrol---6件: 2, 8, 18, 89, 97, 113 💬
79RHuG-CSF----1件: 18 💬
80RILUZOLE1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬9件: 2, 3, 5, 8, 13, 17, 18, 203, 206 💬
81Riluzole PMCS1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 18 💬
82RILUZOLO----3件: 2, 18, 114 💬
83Rokan (r) Novo 120 mg----1件: 18 💬
84Rosuvastatin1件: Rosuvastatin1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬11件: 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬
85Standardized Ginkgo Biloba Extract (EGb 761 (r)1件: Ginkgo biloba---1件: 18 💬
86SUB09246MIG----1件: 18 💬
87TAK-8311件: TAK-831---1件: 18 💬
88VARENICLINE1件: Varenicline1件: Varenicline 💬2件: CHRNA4,
CHRNB2 💬		4件: Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬3件: 6, 18, 53 💬
89VATIQUINONE1件: Vatiquinone1件: Vatiquinone 💬--2件: 18, 21 💬